By Megan McCann
Each year, nearly 800,000 Americans suffer a stroke which can result in permanent brain damage, long term disability or death. As a leading cause of adult disability, stroke has an annual burden of more than $62 billion on the United States economy. With the exception of rehabilitation therapy, very few treatments are available to improve the chronic neurologic deficits caused by a stroke. In hopes of expanding therapeutic options, Northwestern Medicine® researchers are investigating a novel stem cell therapy, known as SB623, that may hold the key to improving motor function following a disabling stroke.
About this Blog
The Northwestern Medicine News Blog features medical news, research innovations, health information and various perspectives—including clinical and medical information as well as other healthcare-related issues. We invite you to share and comment on posts.